Asset Comparison and Correlation
|SK Innovation vs DOC IMBITUBAPN|
Assuming 30 trading days horizon, SK Innovation is expected to under-perform the DOC IMBITUBA. But the stock apears to be less risky and, when comparing its historical volatility, SK Innovation is 2.08 times less risky than DOC IMBITUBA. The stock trades about -0.09 of its potential returns per unit of risk. The DOC IMBITUBAPN is currently generating about 1.07 of returns per unit of risk over similar time horizon. If you would invest 49.00 in DOC IMBITUBAPN on April 25, 2013 and sell it today you would earn a total of 2.00 from holding DOC IMBITUBAPN or generate 4.08% return on investment over 30 days.
Over the last 30 days SK Innovation has generated negative risk-adjusted returns adding no value to investors with long positions.
Match-ups for SK Innovati
42% of all equities and portfolios perform better than DOC IMBITUBAPN. Compared with the overall equity markets, risk-adjusted returns on investments in DOC IMBITUBAPN are ranked lower than 58 (%) of all global equities and portfolios over the last 30 days.
Match-ups for DOC IMBITUBA